Aeterna Zentaris (AEZS) Competitors $2.98 -0.02 (-0.67%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends AEZS vs. MIRA, PIRS, PULM, IBIO, GLYC, CYTH, SPRB, UBX, MEIP, and FNCHShould you be buying Aeterna Zentaris stock or one of its competitors? The main competitors of Aeterna Zentaris include MIRA Pharmaceuticals (MIRA), Pieris Pharmaceuticals (PIRS), Pulmatrix (PULM), iBio (IBIO), GlycoMimetics (GLYC), Cyclo Therapeutics (CYTH), Spruce Biosciences (SPRB), Unity Biotechnology (UBX), MEI Pharma (MEIP), and Finch Therapeutics Group (FNCH). These companies are all part of the "pharmaceutical products" industry. Aeterna Zentaris vs. MIRA Pharmaceuticals Pieris Pharmaceuticals Pulmatrix iBio GlycoMimetics Cyclo Therapeutics Spruce Biosciences Unity Biotechnology MEI Pharma Finch Therapeutics Group Aeterna Zentaris (NASDAQ:AEZS) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, community ranking, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation. Does the media favor AEZS or MIRA? In the previous week, Aeterna Zentaris' average media sentiment score of 0.00 equaled MIRA Pharmaceuticals'average media sentiment score. Company Overall Sentiment Aeterna Zentaris Neutral MIRA Pharmaceuticals Neutral Which has more volatility & risk, AEZS or MIRA? Aeterna Zentaris has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 3.09, suggesting that its stock price is 209% more volatile than the S&P 500. Is AEZS or MIRA more profitable? MIRA Pharmaceuticals has a net margin of 0.00% compared to Aeterna Zentaris' net margin of -760.32%. Aeterna Zentaris' return on equity of -83.45% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Aeterna Zentaris-760.32% -83.45% -45.76% MIRA Pharmaceuticals N/A -337.44%-280.58% Do analysts rate AEZS or MIRA? MIRA Pharmaceuticals has a consensus price target of $14.00, indicating a potential upside of 989.49%. Given MIRA Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe MIRA Pharmaceuticals is more favorable than Aeterna Zentaris.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aeterna Zentaris 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Do institutionals and insiders believe in AEZS or MIRA? 0.7% of Aeterna Zentaris shares are held by institutional investors. Comparatively, 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. 0.1% of Aeterna Zentaris shares are held by company insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has preferable valuation and earnings, AEZS or MIRA? MIRA Pharmaceuticals has lower revenue, but higher earnings than Aeterna Zentaris. MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Aeterna Zentaris, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAeterna Zentaris$2.37M2.25-$16.55M-$14.86-0.20MIRA PharmaceuticalsN/AN/A-$11.98M-$0.56-2.29 Does the MarketBeat Community believe in AEZS or MIRA? Aeterna Zentaris received 416 more outperform votes than MIRA Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave MIRA Pharmaceuticals an outperform vote while only 60.20% of users gave Aeterna Zentaris an outperform vote. CompanyUnderperformOutperformAeterna ZentarisOutperform Votes41960.20% Underperform Votes27739.80% MIRA PharmaceuticalsOutperform Votes3100.00% Underperform VotesNo Votes SummaryMIRA Pharmaceuticals beats Aeterna Zentaris on 11 of the 16 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEZS vs. The Competition Export to ExcelMetricAeterna ZentarisPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.35M$6.48B$5.07B$8.80BDividend YieldN/A8.11%4.99%4.07%P/E Ratio-0.204.9789.5613.60Price / Sales2.25371.451,224.8087.40Price / CashN/A52.5939.4536.27Price / Book0.2010.306.976.33Net Income-$16.55M$153.61M$119.04M$225.93M7 Day Performance-5.05%-1.73%-1.78%-0.96%1 Month Performance-19.44%-7.26%-3.59%1.06%1 Year Performance-56.16%31.10%31.64%26.59% Aeterna Zentaris Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEZSAeterna ZentarisN/A$2.98-0.7%N/A-57.4%$5.35M$2.37M-0.2020Gap DownMIRAMIRA Pharmaceuticals1.6575 of 5 stars$1.29+1.6%$14.00+989.5%-72.8%$21.28MN/A0.002PIRSPieris Pharmaceuticals1.6293 of 5 stars$16.01+2.7%N/A-10.4%$21.13M$42.81M-1.32140Analyst UpgradeNews CoveragePULMPulmatrix0.26 of 5 stars$5.75+2.3%N/A+210.5%$20.99M$7.30M0.0020Analyst ForecastIBIOiBio1.6995 of 5 stars$2.27+3.7%$4.30+89.4%N/A$20.77M$220,000.000.00100Positive NewsGap UpGLYCGlycoMimetics3.442 of 5 stars$0.32-3.5%$10.00+3,040.7%-78.4%$20.53M$10,000.000.0050Gap DownCYTHCyclo Therapeutics2.7699 of 5 stars$0.71+4.4%$0.95+34.0%-47.9%$20.39M$1.08M0.009News CoverageGap UpSPRBSpruce Biosciences2.9764 of 5 stars$0.48-1.0%$4.00+724.9%-64.0%$20.03M$10.09M0.0020UBXUnity Biotechnology3.6059 of 5 stars$1.14-2.6%$8.00+601.8%-42.1%$19.21M$240,000.000.0060MEIPMEI Pharma4.1926 of 5 stars$2.80-2.1%$7.00+150.0%-50.5%$18.65M$65.30M-0.40100FNCHFinch Therapeutics GroupN/A$11.41-0.3%N/A+216.3%$18.37M$110,000.000.00190 Related Companies and Tools Related Companies ENLV Alternatives MIRA Alternatives PIRS Alternatives PULM Alternatives IBIO Alternatives GLYC Alternatives CYTH Alternatives SPRB Alternatives UBX Alternatives MEIP Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AEZS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aeterna Zentaris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aeterna Zentaris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AEZS Stock Alerts